MDT

84.21

+0.41%↑

VEEV

227.67

+3.34%↑

A

106.91

+1.84%↑

WBA

11.03

+0.46%↑

CHE

546.34

-6.7%↓

MDT

84.21

+0.41%↑

VEEV

227.67

+3.34%↑

A

106.91

+1.84%↑

WBA

11.03

+0.46%↑

CHE

546.34

-6.7%↓

MDT

84.21

+0.41%↑

VEEV

227.67

+3.34%↑

A

106.91

+1.84%↑

WBA

11.03

+0.46%↑

CHE

546.34

-6.7%↓

MDT

84.21

+0.41%↑

VEEV

227.67

+3.34%↑

A

106.91

+1.84%↑

WBA

11.03

+0.46%↑

CHE

546.34

-6.7%↓

MDT

84.21

+0.41%↑

VEEV

227.67

+3.34%↑

A

106.91

+1.84%↑

WBA

11.03

+0.46%↑

CHE

546.34

-6.7%↓

Search

Perrigo Co PLC

Closed

SectorHealthcare

24.88 0.48

Overview

Share price change

24h

Current

Min

24.5

Max

25.08

Key metrics

By Trading Economics

Income

-24M

-45M

Sales

51M

1.1B

P/E

Sector Avg

2,570

57.333

EPS

0.93

Dividend yield

4.76

Profit margin

-3.909

Employees

8,379

EBITDA

35M

114M

Recommendations

By TipRanks

Recommendations

Buy

12 Months Forecast

+39.45% upside

Dividends

By Dow Jones

Dividend yield

Sector Avg

4.76%

2.63%

Next Earnings

7 May 2025

Next Dividend date

17 Jun 2025

Next Ex Dividend date

29 May 2025

Market Stats

By TradingEconomics

Market Cap

85M

3.5B

Previous open

24.4

Previous close

24.88

Technical Score

By Trading Central

Confidence

Bearish Evidence

Perrigo Co PLC Chart

Past performance is not a reliable indicator of future results.

Related News

28 Feb 2025, 17:42 UTC

Major Market Movers

Perrigo Shares Jump on FDA's Move to Reclassify Wisconsin Infant-Formula Plant

27 Feb 2025, 23:52 UTC

Earnings

Perrigo Gets Facility Reclassification From FDA as 4Q Profit, Revenue Fall

Peer Comparison

Price change

Perrigo Co PLC Forecast

Price Target

By TipRanks

39.45% upside

12 Months Forecast

Average 34.5 USD  39.45%

High 42 USD

Low 27 USD

Based on 4 Wall Street analysts offering 12 month price targets forPerrigo Co PLC - Dist in the last 3 months.

Rating Consensus

By TipRanks

Buy

4 ratings

2

Buy

2

Hold

0

Sell

Technical Score

By Trading Central

24.09 / 24.825Support & Resistance

Short Term

Bearish Evidence

Intermediate Term

Weak Bullish Evidence

Long Term

Weak Bearish Evidence

Financials

Selling and administration expenses

Operating expenses

Pre-tax profit

Sales

Cost of sales

Gross profit on sales

Interest expense on debt

EBITDA

Operating profit

$

About Perrigo Co PLC

Perrigo Company plc provides over-the-counter health and wellness solutions to enhance individual well-being in the United States, Europe, and internationally. It operates through Consumer Self-Care Americas and Consumer Self-Care International segments. The company develops, manufactures, markets, and distributes self-care consumer products, such as upper respiratory products, including cough suppressants, expectorants, and sinus and allergy relief; nutrition products consisting of infant formulas and nutritional beverages; digestive health products, including antacids, anti-diarrheal, and anti-heartburn; pain and sleep-aids products comprising pain relievers and fever reducers; and oral care products, which include toothbrushes, toothbrush replacement heads, floss, flossers, whitening products, and toothbrush covers. It also offers healthy lifestyle products, such as smoking cessation, well-being, and weight management products; skin care products consisting of dermatological care, scar management, lice treatment, and other products for various skin conditions; women's health products comprising feminine hygiene and contraceptives; vitamins, minerals, and supplements; rare diseases business; and other miscellaneous self-care products. The company sells its products under the Compeed, Dr. Fresh, Firefly, Good Sense, Good Start, Mederma, Nasonex, Plackers, Prevacid24HR, REACH, Rembrandt, Steripod, Opill, Solpadeine, Coldrex, Physiomer, NiQuitin, ACO, ellaOne, Compeed Stops, XLS, Arterin, Davitamon, Apiserum, Abtei, and Nicorette brands. It also offers contract manufacturing services. The company sells its products through retail drug, supermarket, and mass merchandise chains; e-commerce stores; wholesalers; pharmacies; drug and grocery retailers; and para-pharmacies. The company was formerly known as Perrigo Company and changed its name to Perrigo Company plc in December 2013. Perrigo Company plc was founded in 1887 and is headquartered in Dublin, Ireland.